Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Execs claim its U.S. tariff exposure equates to about one quarter of the average for the industry, a significant advantage ...